Home › Calculator › FBIOP Dividend Calculator 2026
FBIOP Dividend DRIP Calculator 2026
10.81% YieldHealthcareFortress Biotech, Inc. · NASDAQ
Price: $18.50 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When FBIOP pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your FBIOP snowball 📈
$10,000 in FBIOP → $27.26 in 10 years · $0.22/month
About Fortress Biotech, Inc. (FBIOP) — Dividend Analysis 2026
Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products. The company markets dermatology products, including Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe recalcitrant nodular acne; Amzeeq, a topical formulation of minocycline for inflammatory lesions of non-nodular moderate to severe acne vulgaris; Zilxi for inflammatory lesions of rosacea; Exelderm, an antifungal cream and solution for topical use; Targadox, an oral doxycycline drug for therapy for severe acne; and Luxamend, a water-based emulsion to provide a moist healing environment for superficial wounds, minor cuts or scrapes, dermal ulcers, donor sites, sunburns, and radiation dermatitis. It also develops intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for Menkes disease; UNLOXCYT for metastatic cutaneous squamous cell carcinoma; Olafertinib for EGFR mutation-positive NSCLC; CAEL-101, a monoclonal antibody for amyloid light chain amyloidosis; and Triplex, a cytomegalovirus vaccine. In addition, the company's early-stage product candidates include Dotinurad for gout; MB-101 for glioblastoma; MB-108 for recurrent GBM; MB-109 for refractory glioblastoma and anaplastic astrocytoma; MB-106 for B-cell non-hodgkin lymphoma; AJ201, an androgen receptor degradation enhancer; and BAER-101, a positive allosteric modulator. Further, its preclinical product candidates comprise AAV-ATP7A and AVTS-001 gene therapies; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; and oligonucleotide platform. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Islands, Florida.
Compare FBIOP with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full FBIOP DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open FBIOP position with:
🌍 FBIOP Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold FBIOP.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 10.81% | 8.01% | $1,081 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 9.19% | 6.39% | $919 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 8.65% | 5.85% | $865 / yr |
| 🇬🇧 UK ISA | 0% | 10.81% | 8.01% | $1,081 / yr |
| 🇬🇧 UK Taxable | 8.75% | 9.86% | 7.06% | $986 / yr |
| 🇨🇦 TFSA | 0% | 10.81% | 8.01% | $1,081 / yr |
| 🇨🇦 CA Taxable | 25% | 8.11% | 5.31% | $811 / yr |
| 🇦🇺 Super (pension) | 15% | 9.19% | 6.39% | $919 / yr |
| 🇦🇺 AU Taxable | 30% | 7.57% | 4.77% | $757 / yr |
| 🇩🇪 DE Taxable | 26.375% | 7.96% | 5.16% | $796 / yr |
| 🇫🇷 FR Taxable | 30% | 7.57% | 4.77% | $757 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 FBIOP Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 FBIOP Dividend Payment Schedule
FBIOP pays quarterly — 4 times per year. Next ex-div: TBD.
📊 FBIOP vs Healthcare Benchmarks
How FBIOP compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for FBIOP sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ FBIOP Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-22 | 400,000 | — | — | ||
| A-Award | 2026-04-01 | 2,967 | $2.18 | $6.5K | ||
| A-Award | 2026-03-18 | 475,424 | — | — | ||
| A-Award | 2026-03-18 | 475,424 | — | — | ||
| A-Award | 2026-01-01 | 27,322 | — | — | ||
| A-Award | 2026-01-01 | 27,322 | — | — | ||
| A-Award | 2026-01-01 | 27,322 | — | — | ||
| A-Award | 2026-01-01 | 27,322 | — | — | ||
| A-Award | 2026-01-01 | 27,322 | — | — | ||
| A-Award | 2025-10-01 | 2,711 | $1.31 | $3.5K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the FBIOP dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Fortress Biotech, Inc. (FBIOP) is currently trading at $18.50, 30% below its 52-week high. The current dividend yield is 10.81% based on an annual payout of $2.00 per share.
FBIOP (Fortress Biotech, Inc.) — 10.81% Dividend Yield Analysis
Fortress Biotech, Inc. (FBIOP) is a healthcare stock currently trading at $18.50 with a dividend yield of 10.81%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, FBIOP has grown its dividend at a compound annual rate of 50.0%.
- Above-average yield (10.81%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest FBIOP News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.